These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34485172)

  • 21. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
    Lepak AJ; Andes DR
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A method for generation phage cocktail with great therapeutic potential.
    Gu J; Liu X; Li Y; Han W; Lei L; Yang Y; Zhao H; Gao Y; Song J; Lu R; Sun C; Feng X
    PLoS One; 2012; 7(3):e31698. PubMed ID: 22396736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and genome analysis of Klebsiella phage P509, with lytic activity against clinical carbapenem-resistant Klebsiella pneumoniae of the KL64 capsular type.
    Li M; Xiao Y; Li P; Wang Z; Qi W; Qi Z; Chen L; Du H; Zhang W
    Arch Virol; 2020 Dec; 165(12):2799-2806. PubMed ID: 32989574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneous
    Qin J; Wu N; Bao J; Shi X; Ou H; Ye S; Zhao W; Wei Z; Cai J; Li L; Guo M; Weng J; Lu H; Tan D; Zhang J; Huang Q; Zhu Z; Shi Y; Hu C; Guo X; Zhu T
    Front Cell Infect Microbiol; 2020; 10():608402. PubMed ID: 33569355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice.
    Hung CH; Kuo CF; Wang CH; Wu CM; Tsao N
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1358-65. PubMed ID: 21245450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Bacteriophage Cocktail on Septicemia Caused by Colistin-Resistant
    Singh A; Singh AN; Rathor N; Chaudhry R; Singh SK; Nath G
    Front Pharmacol; 2022; 13():778676. PubMed ID: 35197852
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of the therapeutic effect of a novel bacteriophage in the healing process of infected wounds with Klebsiella pneumoniae in mice.
    Kelishomi FZ; Nikkhahi F; Amereh S; Ghayyaz F; Marashi SMA; Javadi A; Shahbazi G; Khakpour M
    J Glob Antimicrob Resist; 2024 Mar; 36():371-378. PubMed ID: 38307250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Klebsiella virus UPM2146 lyses multiple drug-resistant Klebsiella pneumoniae in vitro and in vivo.
    Assafiri O; Song AA; Tan GH; Hanish I; Hashim AM; Yusoff K
    PLoS One; 2021; 16(1):e0245354. PubMed ID: 33418559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of antibiotic resistance in bacteriophage-insensitive Klebsiella pneumoniae.
    Uddin MJ; Kim B; Dawan J; Ding T; Kim JC; Ahn J
    Microb Pathog; 2019 Oct; 135():103625. PubMed ID: 31325570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a phage-derived depolymerase specific for KL47 capsule of Klebsiella pneumoniae and its therapeutic potential in mice.
    Li M; Wang H; Chen L; Guo G; Li P; Ma J; Chen R; Du H; Liu Y; Zhang W
    Virol Sin; 2022 Aug; 37(4):538-546. PubMed ID: 35513275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice.
    Chhibber S; Kaur S; Kumari S
    J Med Microbiol; 2008 Dec; 57(Pt 12):1508-1513. PubMed ID: 19018021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
    Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic efficacy of a K5-specific phage and depolymerase against Klebsiella pneumoniae in a mouse model of infection.
    Li P; Guo G; Zheng X; Xu S; Zhou Y; Qin X; Hu Z; Yu Y; Tan Z; Ma J; Chen L; Zhang W
    Vet Res; 2024 May; 55(1):59. PubMed ID: 38715095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection].
    Bogovazova GG; Voroshilova NN; Bondarenko VM
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):5-8. PubMed ID: 1882608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro and In Vivo Assessments of Two Newly Isolated Bacteriophages against an ST13 Urinary Tract Infection
    Laforêt F; Antoine C; Blasdel Reuter B; Detilleux J; Pirnay JP; Brisse S; Fall A; Duprez JN; Delcenserie V; Thiry D
    Viruses; 2022 May; 14(5):. PubMed ID: 35632820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo efficacy of single phage versus phage cocktail in resolving burn wound infection in BALB/c mice.
    Chadha P; Katare OP; Chhibber S
    Microb Pathog; 2016 Oct; 99():68-77. PubMed ID: 27498362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the therapeutic potential of bacteriophage KpV74 and phage-derived depolymerase (β-glucosidase) against Klebsiella pneumoniae capsular type K2.
    Volozhantsev NV; Borzilov AI; Shpirt AM; Krasilnikova VM; Verevkin VV; Denisenko EA; Kombarova TI; Shashkov AS; Knirel YA; Dyatlov IA
    Virus Res; 2022 Dec; 322():198951. PubMed ID: 36191686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fighting MDR-
    Poerio N; Olimpieri T; Henrici De Angelis L; De Santis F; Thaller MC; D'Andrea MM; Fraziano M
    Front Immunol; 2022; 13():835417. PubMed ID: 35237274
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment.
    Lin TL; Hsieh PF; Huang YT; Lee WC; Tsai YT; Su PA; Pan YJ; Hsu CR; Wu MC; Wang JT
    J Infect Dis; 2014 Dec; 210(11):1734-44. PubMed ID: 25001459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.
    Petraitiene R; Petraitis V; Kavaliauskas P; Maung BBW; Khan F; Naing E; Aung T; Zigmantaite V; Grigaleviciute R; Kucinskas A; Stakauskas R; Georgiades BN; Mazur CA; Hayden JA; Satlin MJ; Walsh TJ
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.